In 2001, the FDA published the first version of the Bioanalytical Method Validation (BMV) Guidance for the bioanalysis industry. Over the next 17 years, the FDA would come out with another draft document, followed by a final version in 2018, based on scientist’s laboratory suggestions. Scientists were encouraged to...
Do you want to increase efficiency, enhance connectivity and drive superior quality in your lab? Then you need to attend this year’s SmartLab Digital event. SmartLab Digital is an online series of live interactive webinars with hand-picked case studies by pharmaceutical industry experts and thought leaders all focused on...
Companies are facing increasing pressure to get drugs to market faster on a smaller budget. As a result, organizations are looking to capture data more efficiently and do the most with their data. SaaS provides a solution, tackling some of these challenges head-on – it’s scalable to meet varying...
Maximizing the use of IT through a digital transformation program is undoubtedly challenging for any sector. While many sectors have undergone this process by putting a data-driven approach in place, this has yet to be fully realized in pharmaceuticals. Sam Shah, director of digital development at NHS England has...
How data, AI and machine learning can open the doors to drug discovery and advance personalized medicine. Developing personalized and precision medicine is the next breakthrough for drug developers – particularly for cancer treatments. A recent review paper, from researchers at Rutgers University Department of Biomedicine Engineering, highlights its...
i3 is our annual customer and user group meeting here at IDBS. Each year the event brings our community of R&D and IT professionals together to ignite insights, develop ideas, and advance scientific innovation for the future. Each day at i3 is packed full of inspiring talks and interactive...
In this interview, Unjulie discusses the challenges in the current biologics scene, from business problems through to generating data in the laboratory, and explains how The IDBS Bioprocess Solution can help tackle these issues. Rising competition in the biologics development space means that customers need to achieve the right...
Sadly, Bio Innovation is over for another year. But from our perspective, the event just keeps getting better and better! We feel this is testament to both the effort of the GBX summit team, especially Patrick Basanez for his boundless enthusiasm (which is needed prior to that first coffee...
The biopharmaceutical industry – especially the bioprocessing sector – continues to grow and isn’t showing any signs of slowing down. Last year, we talked about different aspects of the biopharmaceutical industry. These touched on several trends from the importance of data and the extensive use of AI in the...
i3 2018 saw three days of inspiration, innovation, and powerful networking with IDBS experts and fellow IDBS customers. Want to be a part of it this year? Save the date and get ready for i3 2019! Whether you are part of a large pharmaceutical company with 1,000+ users, an enterprise...
